BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8844764)

  • 1. Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis.
    Kavaliers M; Perrot-Sinal TS
    Peptides; 1996; 17(5):763-8. PubMed ID: 8844764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis.
    Kavaliers M; Choleris E; Saucier DM
    Peptides; 1997; 18(7):943-7. PubMed ID: 9357050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist.
    Salvadori S; Guerrini R; Calo G; Regoli D
    Farmaco; 1999; 54(11-12):810-25. PubMed ID: 10668183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats.
    Yu LC; Lu JT; Huang YH; Meuser T; Pietruck C; Gabriel A; Grond S; Pierce Palmer P
    Brain Res; 2002 Jul; 945(1):88-96. PubMed ID: 12113955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.
    Meunier JC; Mollereau C; Toll L; Suaudeau C; Moisand C; Alvinerie P; Butour JL; Guillemot JC; Ferrara P; Monsarrat B
    Nature; 1995 Oct; 377(6549):532-5. PubMed ID: 7566152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli.
    Wang XM; Zhang KM; Mokha SS
    J Neurophysiol; 1996 Nov; 76(5):3568-72. PubMed ID: 8930296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis.
    Saksida LM; Galea LA; Kavaliers M
    Peptides; 1993; 14(4):763-5. PubMed ID: 8234022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites.
    Rossi GC; Pellegrino M; Shane R; Abbadie CA; Dustman J; Jimenez C; Bodnar RJ; Pasternak GW; Allen RG
    J Pharmacol Exp Ther; 2002 Jan; 300(1):257-64. PubMed ID: 11752124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
    Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
    J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
    Kotlińska J; Suder P; Sciubisz A; Łegowska A; Eilmes J; Rolka K; Silberring J
    Eur J Pharmacol; 2001 May; 419(1):33-7. PubMed ID: 11348627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of kappa- and mu-opioid receptor agonists on Ca2+ channels in neuroblastoma cells: involvement of the orphan opioid receptor.
    Hurlé MA; Sánchez A; García-Sancho J
    Eur J Pharmacol; 1999 Aug; 379(2-3):191-8. PubMed ID: 10497906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
    Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
    FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
    Mandyam CD; Altememi GF; Standifer KM
    Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
    Chu X; Xu N; Li P; Mao L; Wang JQ
    Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
    Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution conformation of nociceptin.
    Salvadori S; Picone D; Tancredi T; Guerrini R; Spadaccini R; Lazarus LH; Regoli D; Temussi PA
    Biochem Biophys Res Commun; 1997 Apr; 233(3):640-3. PubMed ID: 9168905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.